Raphael Pharmaceutical Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Raphael Pharmaceutical Inc. (RAPH) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $111.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2023-08-09
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $111.00K.
- 2023-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $38.00K.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $288.00K.
- 2022-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $93.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2023-06-30 | $111.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $38.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $288.00K 10-Q · filed 2023-08-09 |
| 2022-09-30 | $93.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $135.00K 10-Q · filed 2023-08-09 |
| 2022-03-31 | $81.00K 10-Q · filed 2023-05-15 |
| 2021-12-31 | $153.00K 10-Q · filed 2023-08-09 |
| 2021-09-30 | $37.00K 10-Q · filed 2022-11-14 |
| 2021-06-30 | $218.00K 10-Q · filed 2022-08-12 |
| 2021-03-31 | $10.00K 10-Q · filed 2022-05-16 |
| 2020-12-31 | $95.00K 10-K/A · filed 2023-05-25 |